Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Fresenius Medical Care AG ADR (NYSE: FMS) closed at $23.64 down -1.46% from its previous closing price of $23.99. In other words, the price has decreased by -$1.46 from its previous closing price. On the day, 0.51 million shares were traded.
Ratios:
For a deeper understanding of Fresenius Medical Care AG ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.60. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.38. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.67.
On November 06, 2024, Berenberg started tracking the stock assigning a Buy rating and target price of $25.60.
Valuation Measures:
As of this moment, Fresenius’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.76, and their Forward P/E ratio for the next fiscal year is 10.34. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.66 while its Price-to-Book (P/B) ratio in mrq is 0.92.
Stock Price History:
Over the past 52 weeks, FMS has reached a high of $25.96, while it has fallen to a 52-week low of $17.93. The 50-Day Moving Average of the stock is -1.46%, while the 200-Day Moving Average is calculated to be 7.81%.
Shares Statistics:
A total of 586.83M shares are outstanding, with a floating share count of 586.39M. Insiders hold about 0.07% of the company’s shares, while institutions hold 5.82% stake in the company.
